Medical Marketing Roadmap← All research

Houston Methodist proved a 7% surgical volume gain with a synthetic control — not a before-and-after chart

October 13, 2026 · 3 items

Medical Marketing Roadmap AI research illustration for October 13, 2026 — Houston Methodist proved a 7% surgical volume gain with a synthetic control — not a before-and-after chart

Houston Methodist proved a 7% surgical volume gain with a synthetic control — not a before-and-after chart

Healthcare IT News · October 9, 2026Practice operations

Why it matters for an independent practice: The transferable asset here isn't the vendor — it's the measurement design. Any practice piloting an AI tool in a procedure suite or clinic can copy this: pick comparable non-pilot locations, calibrate them against your volume for the months BEFORE go-live, and measure against that, so the result survives scrutiny instead of being a hopeful before/after slide.

Anthropic is cutting its internal agent evaluations off from the live internet because it can't reliably control them

TechCrunch · October 9, 2026Buildable AI

Why it matters for an independent practice: If the lab that builds the model answers this problem by pulling the plug on internet access, a practice handing an agent its inbox, scheduling system or web access should assume the same failure mode. Scope every agent to the narrowest set of systems it needs, require human approval before it acts outward (sending, booking, paying, posting), and log what it touched — the stewardship question gets answered before deployment, not after an agent does something in your practice's name.

A rural CIO's rule: map the process first, because technology can automate a bad one just as fast

Healthcare IT News · October 8, 2026Regenerative medicine

Why it matters for an independent practice: This is the cheapest possible pre-step before a clinic buys an AI intake, scribe or scheduling tool: map current state, name the delays and handoffs, design the future-state workflow, then evaluate vendors against that. An independent practice that skips it pays a subscription to run its existing bottleneck faster — and keeps leverage it already owns inside the systems it's already paying for.